The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Antibiotic-resistant bacteria causes 700,000 deaths annually, but there are strategies we can use to slow the rapid rise of these superbugs.
Dummy text
